- 
							【GE CHENG News】"Annual Report on China’s Intellectual Property Operations (2022)" released2025-05-08The "Report" shows that in 2022, Chinas patent enforcement and application levels has steadily improved, and the total number of patent transfers, licenses, pledges and other operations nationwide reached 507,000, of which 37 key cities for the construction of intellectual property operation service
- 
							【GE CHENG News】The average number of patent applications from biotech companies on the Beijing Stock Exchange has the largest increase2025-05-08On November 15, 2023, the Beijing Stock Exchange celebrated its second anniversaryof the opening. Classified by strategic emerging industries, according to Smart Bud statistics, the 229 listed companies on the Beijing Stock Exchange are distributed most in the new generation information technology,
- 
							【GE CHENG News】The number of patent applications for China’s next-generation Internet technology exceeds 1.7 million in decade2025-05-08The "Analysis of Key Technology Patents of Next-Generation Internet" (hereinafter referred to as "Analysis") released by the China Intellectual Property Society in Shenzhen on the 16th shows that in the past decade, the number of patent applications for next-generation Internet technology in the wor
- 
							【GE CHENG News】Disputes over photovoltaic patent arise again, AIKO denies ABC battery infringement2025-05-08After the dispute with Tongwei Co., Ltd. (600438.SH), Maxeon sued a Chinese photovoltaic company for patent infringement this year.On November 15, solar panel manufacturer Maxeon Solar Technologies (MAXN, hereinafter referred to as Maxeon) filed a patent infringement lawsuit in a German court agains
- 
							【GE CHENG News】There have been over 800 patent applications related to pancreatic cancer in China2025-05-08TianYianCha App shows that there are more than 800 patent applications on "pancreatic cancer" in China, over 180 of which have been authorized, mostly concerning pancreatic cancer detection, prevention, and treatment, including "Application of LMO7 expression level in predicting gemcitabine resistan
 
			